Related Experiment Video
Updated: Apr 23, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Foregoing medicines in the former Soviet Union: changes between 2001 and 2010
Katharine Footman1, Erica Richardson2, Bayard Roberts1
1European Centre on Health of Societies in Transition, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.
Many in former Soviet countries struggle to afford medicines, but rates of foregoing essential drugs decreased between 2001 and 2010. Policy reforms significantly improved access, highlighting the need for continued pharmaceutical reform to ensure equitable healthcare.
Area of Science:
- Health Economics
- Pharmaceutical Policy
- Public Health
Background:
- High out-of-pocket pharmaceutical expenses in former Soviet countries threaten financial equity and healthcare access.
- Understanding trends in medicine affordability is crucial for public health policy.
Purpose of the Study:
- To compare the proportion of the population foregoing medicines in 2001 and 2010 across eight former Soviet countries.
- To analyze disparities in medicine access based on economic status and geographic location (urban/rural).
Main Methods:
- Analysis of nationally representative household survey data from Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, and Ukraine.
- Comparison of medicine non-adherence rates between 2001 and 2010.
- Subgroup analysis by economic status and urban/rural populations.
Main Results:
- A substantial percentage of the population reported foregoing medicines in 2010, ranging from 29.2% in Belarus to 72.9% in Georgia.
- Overall decline in people foregoing medicines from 2001 to 2010, with significant improvements in Moldova and Kyrgyzstan.
- Limited improvement in countries with higher Gross National Income (GNI) per capita, and wealthier, urban populations benefited more than poorer, rural households in some nations.
Conclusions:
- Pharmaceutical reforms, including price controls and expanded benefits, correlate with greater improvements in medicine access.
- Continued commitment to pharmaceutical reform is essential to prevent individuals from being unable to afford necessary medications.
- Addressing socioeconomic and geographic disparities in medicine access remains a critical public health challenge.
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Regulation
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Factors Affecting Drug Response: Overview
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

